dianosic Information

Dianosic is a clinical-stage biotechnology company founded in 2017. The company develops complex intranasal formulations and advanced intranasal drug-delivery solutions for chronic respiratory diseases and central nervous system disorders. Dianosic initially focused on long-acting intranasal solid dosage forms for chronic rhinosinusitis and chronic allergic rhinitis before expanding its technology toward CNS applications, particularly schizophrenia. This development has led to a proprietary platform designed to accommodate different active pharmaceutical ingredients, therapeutic payloads and release profiles across multiple respiratory and CNS indications. Click here to learn more about our solutions: https://bit.ly/3Tnagog 📞 For more information, please contact us via LinkedIn private message, by mail (contact@dianosic.com) or phone (+33 1 44 04 45 80).